Yang Xia

25PUBLICATIONS
65CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersMolecular targetsSemi- and unsupervised learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 14, 2026
Intracranial Efficacy of Crizotinib and Postprogression Therapeutic Strategies in Advanced c-ros Oncogene 1 (ROS1)-Positive Non-Small Cell Lung Cancer (NSCLC), a Multicenter Real-World Study.

|Jun 24, 2026
Retraction Note: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.

|Apr 03, 2026
Dynamic T-Cell Reprogramming Modulates the Treatment Outcome of Neoadjuvant Immunochemotherapy in Non-Small-Cell Lung Cancer.

Rui Jin, Anhao Tian, Weina Lu

|Feb 25, 2026
Negative trial but positive lesson: reframing immunotherapy resistance from one-size-fits-all to precision strategies.

Yuxin Jiang, Youzu Xu, Yang Xia

|Feb 02, 2026
Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.

Zhe Huang, Liang Zeng, Zhaohui Ruan

|Dec 08, 2025
Precise diagnosis of small invasive pulmonary nodules driven by single-cell immune signatures in peripheral blood.

Yang Xia, Yin Zhu, Sai Zhang

Pageof 5

Frequent Collaborators

4 joint publications

Yongchang Zhang

3 joint publications

Panwen Tian

3 joint publications

Tony Mok

3 joint publications

Wenxian Wang